USCA RIA’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $5.14M | Sell |
76,998
-15,719
| -17% | -$1.02M | 0.31% | 97 |
|
|
2021
Q1 | $5.85M | Sell |
92,717
-14,297
| -13% | -$890K | 0.38% | 71 |
|
|
2020
Q4 | $6.64M | Sell |
107,014
-6,114
| -5% | -$376K | 0.47% | 46 |
|
|
2020
Q3 | $6.82M | Sell |
113,128
-19,590
| -15% | -$1.18M | 0.53% | 39 |
|
|
2020
Q2 | $7.8M | Buy |
132,718
+12,789
| +11% | +$765K | 0.69% | 28 |
|
|
2020
Q1 | $6.68M | Sell |
119,929
-3,768
| -3% | -$230K | 0.78% | 27 |
|
|
2019
Q4 | $7.94M | Buy |
123,697
+15,915
| +15% | +$911K | 0.71% | 30 |
|
|
2019
Q3 | $5.47M | Buy |
107,782
+4,120
| +4% | +$194K | 0.54% | 57 |
|
|
2019
Q2 | $4.7M | Sell |
103,662
-57,618
| -36% | -$2.68M | 0.48% | 61 |
|
|
2019
Q1 | $7.7M | Buy |
161,280
+134,171
| +495% | +$6.68M | 0.84% | 28 |
|
|
2018
Q4 | $1.41M | Sell |
27,109
-17,219
| -39% | -$925K | 0.19% | 141 |
|
|
2018
Q3 | $2.75M | Sell |
44,328
-1,193
| -3% | -$70.8K | 0.28% | 116 |
|
|
2018
Q2 | $2.52M | Sell |
45,521
-3,735
| -8% | -$202K | 0.27% | 119 |
|
|
2018
Q1 | $3.12M | Sell |
49,256
-10,170
| -17% | -$654K | 0.34% | 82 |
|
|
2017
Q4 | $3.64M | Sell |
59,426
-56,969
| -49% | -$3.56M | 0.4% | 75 |
|
|
2017
Q3 | $6.49M | Hold |
116,395
| – | – | 0.84% | 25 |
|
|
2017
Q2 | $6.49M | Buy |
116,395
+66,872
| +135% | +$3.64M | 0.83% | 25 |
|
|
2017
Q1 | $2.69M | Buy |
49,523
+8,814
| +22% | +$483K | 0.39% | 70 |
|
|
2016
Q4 | $2.38M | Buy |
40,709
+3,297
| +9% | +$180K | 0.37% | 76 |
|
|
2016
Q3 | $2.02M | Buy |
37,412
+18,700
| +100% | +$1.2M | 0.33% | 89 |
|
|
2016
Q2 | $1.38M | Sell |
18,712
-1,192
| -6% | -$84.2K | 0.23% | 129 |
|
|
2016
Q1 | $1.27M | Buy |
19,904
+486
| +3% | +$30.6K | 0.23% | 129 |
|
|
2015
Q4 | $1.34M | Sell |
19,418
-174
| -0.9% | -$11.5K | 0.29% | 107 |
|
|
2015
Q3 | $1.16M | Sell |
19,592
-137
| -0.7% | -$8.69K | 0.29% | 98 |
|
|
2015
Q2 | $1.31M | Buy |
19,729
+1,178
| +6% | +$77.6K | 0.35% | 77 |
|
|
2015
Q1 | $1.2M | Buy |
18,551
+3,241
| +21% | +$203K | 0.32% | 84 |
|
|
2014
Q4 | $904K | Sell |
15,310
-1,015
| -6% | -$57.2K | 0.25% | 106 |
|
|
2014
Q3 | $835K | Buy |
16,325
+335
| +2% | +$16.7K | 0.25% | 116 |
|
|
2014
Q2 | $776K | Buy |
15,990
+1
| +0% | +$49 | 0.26% | 113 |
|
|
2014
Q1 | $831K | Sell |
15,989
-314
| -2% | -$16.7K | 0.3% | 108 |
|
|
2013
Q4 | $867K | Sell |
16,303
-6,176
| -27% | -$315K | 0.35% | 90 |
|
|
2013
Q3 | $1.04M | Sell |
22,479
-552
| -2% | -$24.2K | 0.47% | 64 |
|
|
2013
Q2 | $1.03M | Buy |
+23,031
| New | +$1,000K | 0.52% | 48 |
|
Other funds holding BMY
USCA RIA's BMY Position: Q2 2021 in Review
USCA RIA reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2021, selling an estimated $1.02M and leaving 76,998 shares worth $5.14M. The position accounts for 0.31% of the portfolio, ranked #97.
USCA RIA first reported a position in BMY in Q2 2013 and has held it in 33 quarters since. The position peaked at $7.94M in Q4 2019. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- USCA RIA held 76,998 shares of Bristol-Myers Squibb worth $5.14M as of Q2 2021.
- USCA RIA sold 15,719 Bristol-Myers Squibb shares in Q2 2021, an estimated $1.02M.
- Bristol-Myers Squibb made up 0.31% of USCA RIA's portfolio in Q2 2021, its #97 holding.
- USCA RIA first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 33 quarters since.
- USCA RIA's Bristol-Myers Squibb position peaked at $7.94M in Q4 2019.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.